Correlation between abdominal obesity and hyperuricaemia in individuals with type 2 diabetes mellitus: A case–control study


Here are the Correlation between abdominal obesity and hyperuricaemia in individuals with type 2 diabetes mellitus: A case–control study journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.

Prevalence of obesity and associated, what is abdominal obesity, correlation between obesity and diabetes, anatomy and physiology of obesity, the physiology of obesity.

Correlation between abdominal obesity and hyperuricaemia in individuals with type 2 diabetes mellitus: A case–control study

Background: Obesity is associated with hyperuricaemia in the general population; however, that relationship has not been studied in detail in patients with type 2 diabetes mellitus (T2DM), nor has the possibility of sex differences in that relationship been investigated.

Methods: A retrospective case–control study was conducted. We explored the correlation between abdominal obesity and hyperuricaemia among 315 Chinese patients with T2DM aged 27–64 years who had received community health services between January 2021 and August 2022. Abdominal obesity was defined as a waist circumference ≥ 85.0 cm in females and ≥ 90.0 cm in males. Hyperuricaemia was defined as a serum uric acid level > 7.0 mg/dL in males and postmenopausal females, > 6.0 mg/dL in premenopausal females, or receiving medical treatment for hyperuricaemia. The male and female groups were each separately divided into two additional groups: those with abdomina l obesity and those without abdominal obesity. Odds ratios (OR) and 95 % confidence intervals (CI) for the risk of hyperuricaemia were calculated using a logistic regression model.

Results: The prevalence of hyperuricaemia in male and female patients in the study area was 42.86 % and 28.00 %, respectively. Abdominal obesity (OR = 3.369, 95 % CI = 1.031–11.009, P value <0.05) was the determinant variable for hyperuricaemia among male patients with T2DM but not among female patients. There was no significant difference in the prevalence of hyperuricaemia between male or female T2DM patients with different body mass index (BMI) levels. Conclusions: Our study revealed that abdominal obesity, but not overall obesity, was associated with an increased risk of hyperuricaemia in male patients with T2DM. Neither abdominal obesity nor overall obesity was associated with an increased risk of hyperuricaemia in female patients with T2DM. Abdominal obesity is a more effec tive predictor of hyperuricaemia than overall obesity is in male patients with T2DM. © 2025 The Authors

Authors : Liu R.; Zhang Y.; Hu Z.; Deng H.

Source : Elsevier B.V.

Article Information

Year 2025
Type Article
DOI 10.1016/j.endmts.2025.100216
ISSN 26663961
Volume 17

You can download the article here


If You have any problem, contact us here


Support Us:

Download Now Buy me a coffee Request Paper Here